Replimune Group (NASDAQ:REPL) Coverage Initiated by Analysts at Cantor Fitzgerald
Stock analysts at Cantor Fitzgerald initiated coverage on shares of Replimune Group (NASDAQ:REPL – Get Free Report) in a report released on Friday, MarketBeat reports. The firm set an “overweight” rating on the stock. REPL has been the topic of a number of other research reports. JPMorgan Chase & Co. boosted their price target on […]
Stock analysts at Cantor Fitzgerald initiated coverage on shares of Replimune Group (NASDAQ:REPL – Get Free Report) in a report released on Friday, MarketBeat reports. The firm set an “overweight” rating on the stock. REPL has been the topic of a number of other research reports. JPMorgan Chase & Co. boosted their price target on […]
